Differences in drug availability levels before and during the covid19 pandemic in the pharmaceutical installation of NTB provincial hospital

Main Article Content

M. Ari Wisnu
Rina Herowati
Samuel Budi Harsono

Abstract

Health services are now increasingly needed during the COVID-19 pandemic which threatens public health. The need for public medicines that must be available such as flu, cough, vitamin c, antibiotics and antimalarials and antivirals for health services makes hospitals must try to fulfil and currently the COVID-19 pandemic situation is still continuing so hospitals must be ready to provide health services to patients.This study aims to determine the differences in drugs in the Pharmacy Installation of the NTB Provincial Hospital before the COVID-19 pandemic in 2019 and during the COVID-19 pandemic in 2020. This study is a descriptive-evaluative study with retrospective data collection in 2019 which represents the period before the COVID-19 pandemic and 2020 which represents the COVID-19 pandemic. The samples used in the study consisted of drug data from the Pharmacy Installation of the NTB Province Regional General Hospital (RSUD) and were analyzed using the Wilcoxon test. The results obtained are the level of drug availability in the pharmaceutical installation of the NTB Provincial Hospital obtained based on the results of observing data in 2019 and 2020, namely 19 and 37 months. There is a significant difference (Asymp. Sig (2-tailed) 0.000) the level of drug availability in the Pharmacy Installation of the NTB Provincial Hospital before and during the COVID-19 pandemic in 2020 with a difference of 18 months.

Article Details

How to Cite
Wisnu, M. A., Herowati, R., & Harsono, S. B. (2024). Differences in drug availability levels before and during the covid19 pandemic in the pharmaceutical installation of NTB provincial hospital. Journal of Health Management and Pharmacy Exploration, 2(1). https://doi.org/10.52465/johmpe.v2i1.192
Section
Articles

References

Menteri Kesehatan Republik Indonesia, “Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016 Tentang Standar Pelayanan Kefarmasian Di Rumah Sakit.” hal. 1–63, 2016.

R. GÜNER, İ. HASANOĞLU, dan F. AKTAŞ, “COVID-19: Prevention and control measures in community,” TURKISH J. Med. Sci., vol. 50, no. SI-1, hal. 571–577, Apr 2020, doi: 10.3906/sag-2004-146.

K. Pauwels, I. Huys, M. Casteels, dan S. Simoens, “Drug shortages in European countries: A trade-off between market attractiveness and cost containment?,” BMC Health Serv. Res., vol. 14, no. 1, 2014, doi: 10.1186/1472-6963-14-438.

C. Deana et al., “Learning from the italian experience during covid-19 pandemic waves: Be prepared and mind some crucial aspects,” Acta Biomed., vol. 92, no. 2, 2021, doi: 10.23750/abm.v92i2.11159.

T. Bochenek et al., “Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian Countries,” Front. Pharmacol., vol. 8, no. JAN, 2018, doi: 10.3389/fphar.2017.00942.

F. A. Rosmania dan S. Supriyanto, “Analisis Pengelolaan Obat Sebagai Dasar Pengendalian Safety Stock pada Stagnant dan Stockout Obat,” J. Adm. Kesehat. Indones., vol. 3, no. 1, hal. 1, Jan 2015, doi: 10.20473/jaki.v3i1.2015.1-10.

N. Oktaviani, G. Pamudji, dan Y. Kristanto, “Evaluasi Pengelolaan Obat Di Instalasi Farmasi Rumah Sakit Umum Daerah Provinsi NTB Tahun 2017 Drug Management Evaluation in Pharmacy Department of NTB Province Regional Hospital during 2017 Period Rumah sakit adalah Institusi kesehatan yang pelayanan kes,” J. Farm. Indones., vol. 15, no. 2, hal. 135–147, 2018.

R. Lodha dan S. K. Kabra, “COVID-19: How to Prepare for the Pandemic?,” Indian J. Pediatr., vol. 87, no. 6, hal. 405–408, 2020, doi: 10.1007/s12098-020-03293-0.

N. Ayati, P. Saiyarsarai, dan S. Nikfar, “Short and long term impacts of COVID-19 on the pharmaceutical sector,” DARU J. Pharm. Sci., vol. 28, no. 2, hal. 799–805, Des 2020, doi: 10.1007/s40199-020-00358-5.

S. Mudenda et al., “Knowledge, Attitude, and Practices of Community Pharmacists on Antibiotic Resistance and Antimicrobial Stewardship in Lusaka, Zambia,” J. Biomed. Res. Environ. Sci., vol. 2, no. 10, hal. 1005–1014, Okt 2021, doi: 10.37871/jbres1343.

S. Mudenda et al., “Self-medication and its Consequences during & after the Coronavirus Disease 2019 (COVID-19) Pandemic: A Global Health Problem,” Eur. J. Environ. Public Heal., vol. 5, no. 1, hal. em0066, Nov 2020, doi: 10.29333/ejeph/9308.

A. Zhang, E. V. Hobman, P. De Barro, A. Young, D. J. Carter, dan M. Byrne, “Self-Medication with Antibiotics for Protection against COVID-19: The Role of Psychological Distress, Knowledge of, and Experiences with Antibiotics,” Antibiotics, vol. 10, no. 3, hal. 232, Feb 2021, doi: 10.3390/antibiotics10030232.

L.-A. O. Ngo Bibaa, “Primary health care beyond COVID-19: dealing with the pandemic in Cameroon,” BJGP Open, vol. 4, no. 4, hal. 1–4, Sep 2020, doi: 10.3399/bjgpopen20X101113.

Kemenkes RI, Petunjuk Teknis Pelayanan Puskesmas Pada Masa Pandemi Covid-19. 2020.

F. P. Gurning, S. F. Siregar, U. R. Siregar, R. Rusmayanti, dan F. Nurhasanah, “Analisis Manajemen Pengelolaan Obat Pada Masa Pandemi Di Puskesmas Sering Kecamatan Medan Tembung,” J. Kesehat. Masy., vol. 9, no. 5, hal. 688–695, 2021, doi: 10.14710/jkm.v9i5.30742.

E. Wulandari dan A. Widayati, “Evaluasi Pengelolaan Obat Di Puskesmas Salaman 1 Kabupaten Magelang Dalam Masa Pandemi Covid-19 Tahun 2020 Evaluation of Drug Management in Salaman 1 Primary Health Center Magelang During the Covid 19 Pandemic,” Jfsp, vol. 7, no. 2, hal. 2579–4558, 2021.

A. C. Widodo, Slamet; Sjaaf, “Gambaran Manajemen Logistik Kefarmasian pada Masa Pandemi COVID-19 di Rumah Sakit Umum Bhakti Asih Brebes Jawa Tengah,” J. Med. Hutama, vol. 03, no. 02, hal. 2047–2053, 2022.

A. E. Polii, Stacey; Posangi, Jimmy ;Manampiring, “Sam Ratulangi,” J. Public Health (Bangkok)., vol. 2, no. 1, hal. 7–13, 2021.

K. B. Ardella, “Risiko Kesehatan Akibat Perubahan Pola Makan Dan Tingkat Aktivitas Fisik Selama Pandemi Covid-19,” J. Med. Hutama, vol. 02, no. 01, hal. 292–297, 2020.

S. Y. Ahmad Gugun Gunawan, Budimanan, Setiawati dan I. Iin, “Kualitas Pelayanan Terhadap Minat Pasien Dalam Memanfaatkan Kembali Jasa Pelayanan Rawat Jalan,” vol. 13, no. 1, hal. 1–11, 2022.

H. Wati dan R. Elly, “Analisis Faktor-Faktor Yang Mempengaruhi Ketersediaan Obat Di Era Jkn Pada Rsud Dr. Saiful Anwar Malang,” Java Heal. J., vol. 5, no. 1, 2018.

Sabarudin, S. Ihsan, H. Kasmawati, R. Mahmudah, dan E. Febriana, “Dampak Pandemi Covid-19 Terhadap Pengelolaan dan Tingkat Ketersediaan Obat di Puskesmas Puuwatu Kota Kendari,” J. Farm. Sains dan Prakt., vol. 7, no. 3, hal. 306–312, 2021.

Y. M. Indriana, E. S. Darmawan, dan A. C. Sjaaf, “Analisis Pengelolaan Obat di Instalasi Farmasi RSUA Tahun 2020,” Promot. J. Kesehat. Masy., vol. 11, no. 1, hal. 10–19, 2021, doi: 10.56338/pjkm.v11i1.1512.

“10 penyakit terbanyak pasien rawat inap tahun 2019,” General Hospital of West Nusa Tenggara Province. .

“10 penyakit terbanyak pasien rawat inap tahun 2020,” General Hospital of West Nusa Tenggara Province.

Abstract viewed = 181 times